Unfortunately, we must cancel this announced Good Morning Meeting!
We are pleased to invite you to our Good Morning Meeting on Enabling New Product and Technological Developments in the Medicon Valley with ThermoFisher.
ThermoFisher Scientific’s portfolio of products for the Life Science and Healthcare market is so diverse it provides a unique opportunity to partner and support companies, who are developing new technologies, pharmaceuticals or diagnostics, in a way that can offer a whole solution from manufacturing through to product supply and commercial kit creation.
This Good Morning Meeting will focus on the areas of molecular and immuno-diagnostic applications with particular focus on how we can partner companies to bring their ideas to the market through product customisation, R&D support for assay development and manufacturing expertise.
Date: Tuesday August 15th, 2017
Time: 8:30 – 10:30
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 15, Copenhagen S – Ground floor
The Good Morning Meeting is FREE, but please make sure to register:
PROGRAM
|
08.30-09.00 |
Coffee and networking |
|
09.00-10.00 |
Partnering in Immuno and Molecular Diagnostics; Supplying unique custom components, manufacturing capability and kit manufacture Q & A |
|
10.00-10.30 |
Networking |
SPEAKERS
|
|
Peter Holden Dr. Peter Holden has 15 years’ sales and business development experience with DNA/RNA related products at Thermofisher Scientific. His current role is as a Business Development Manager working across the UK and Nordic regions supporting custom and commercial supply of molecular based products to Biotech, Pharma and Diagnostic kit companies. Prior to this he worked as a Senior Research Scientist at AstraZeneca, UK where he was involved in setting up microarray platforms to identify the molecular basis of drug toxicity |
|
|
Torsten Knüttel Dr. Torsten Knüttel has 15+ years’ experience from pharma R&D at GE Healthcare and from the medical device industry at Thermo Fisher Scientific. At GE Healthcare he was a Senior Project Manager overseeing the establishment of PET tracer manufacturing sites for oncology clinical trials in Europe, the United States and Asia. At Thermo Fisher Scientific he is the Business Development Manager covering the Nordic countries, responsible for the commercial immunodiagnostic portfolio. |
IN COLLABORATION WITH
